Nano Dimension defends Infinite Epigenetics deal amid shareholder pushback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination
June 16, 2026 7:43 PM EDTWALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (Nano Dimension, Nano, or the Company) and Infinite Epigenetics (Infinite Epigenetics, Infinite) today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinsons recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement... More
